Treatment decisions depend on provider evaluation and clinical appropriateness
Medically supervised weight loss with local support Vital Flow helps you choose the right weight loss medication path with provider-guided care, lab review, and clear follow-through from a local team
There is no established treatment, and once vision is lost, it rarely returns fully
In recent years, GLP-1 drugs like Wegovy and Ozempic have surged in popularity, primarily due to their effectiveness in managing weight loss and diabetes
The half-life is approximately five days, meaning steady-state is reached after four to five weeks at any given dose
Their blood sugar effects are substantial: Semaglutide: Reduces A1c by 1.5-1.8% from baseline (Ozempic trials) Tirzepatide: Reduces A1c by 2.0-2.3% from baseline (SURPASS trials)